MediciNova Secures European Patent for MN-166 Plus Riluzole
The European Patent Office will grant MediciNova a patent that covers the combination of MN-166 (ibudilast) and riluzole…
Articles by Marisa Wexler, MS
#AANAM – Trial Will Evaluate Tofersen in Presymptomatic SOD1 Patients
Editor’s note: The ALS News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22.
3D Imaging System May Have Applications in ALS Research
A novel system for three-dimensional (3D) imaging of zebrafish may be useful for studying the motor and neuronal deficits linked…
Stretchable Electronics May Allow Wearable Sensors to Diagnose ALS
Stretchable electronics that are “intrinsically” stretchable — meaning they have tissue-like mechanical properties that integrate sensory devices with human skin…
Imaging Technique Measures Mitochondrial Abnormalities in ALS
An imaging technique, called 31-phosphorus magnetic resonance spectroscopy (MRS), can be used to assess mitochondrial abnormalities in people with…
TDP-43 Protein Abnormalities in ALS Linked to DNA Damage
Abnormalities in the activity of the protein TDP-43, whose gene is often mutated in amyotrophic lateral sclerosis (ALS), can…
Melatonin Might Benefit ALS Patients, But More Research Needed
People with amyotrophic lateral sclerosis (ALS) who use melatonin have better survival outcomes and experience slower disease progression, a…
Pooling Imaging Data May Make Multi-center Clinical Trials Easier
Imaging data of brain inflammation in people with amyotrophic lateral sclerosis (ALS) that is obtained using different tracers and…
Human Cell Model Captures Brain and Muscle Interaction for 1st Time
A system using human cells to model how the brain controls muscle movement has been developed for the first time,…
Target ALS Awards 4 Grants for Work Into Biomarker Discovery
Target ALS, a nonprofit working to advance research, has awarded a second round of grants supporting four projects that…